E-cigarette vaping associated acute lung injury (EVALI): state of science and future research needs
- 16 March 2022
- journal article
- review article
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 52 (3) , 188-220
Abstract
“E-Cigarette (e-cig) Vaping-Associated Acute Lung Injury” (EVALI) has been linked to vitamin-E-acetate (VEA) and Δ-9-tetrahydrocannabinol (THC), due to their presence in patients’ e-cigs and biological samples. Lacking standardized methodologies for patients’ data collection and comprehensive physicochemical/toxicological studies using real-world-vapor exposures, very little data are available, thus the underlying pathophysiological mechanism of EVALI is still unknown. This review aims to provide a comprehensive and critical appraisal of existing literature on clinical/epidemiological features and physicochemical-toxicological characterization of vaping emissions associated with EVALI. The literature review of 161 medical case reports revealed that the predominant demographic pattern was healthy white male, adolescent, or young adult, vaping illicit/informal THC-containing e-cigs. The main histopathologic pattern consisted of diffuse alveolar damage with bilateral ground-glass-opacities at chest radiograph/CT, and increased number of macrophages or neutrophils and foamy-macrophages in the bronchoalveolar lavage. The chemical analysis of THC/VEA e-cig vapors showed a chemical difference between THC/VEA and the single THC or VEA. The chemical characterization of vapors from counterfeit THC-based e-cigs or in-house-prepared e-liquids using either cannabidiol (CBD), VEA, or medium-chain triglycerides (MCT), identified many toxicants, such as carbonyls, volatile organic compounds, terpenes, silicon compounds, hydrocarbons, heavy metals, pesticides and various industrial/manufacturing/automotive-related chemicals. There is very scarce published toxicological data on emissions from THC/VEA e-liquids. However, CBD, MCT, and VEA emissions exert varying degrees of cytotoxicity, inflammation, and lung damage, depending on puffing topography and cell line. Major knowledge gaps were identified, including the need for more systematic-standardized epidemiological surveys, comprehensive physicochemical characterization of real-world e-cig emissions, and mechanistic studies linking emission properties to specific toxicological outcomes.Keywords
Funding Information
- NIH
This publication has 269 references indexed in Scilit:
- Case Report of Electronic Cigarettes Possibly Associated with Eosinophilic Pneumonitis in a Previously Healthy Active-duty SailorThe Journal of Emergency Medicine, 2014
- Identification of toxicants in cinnamon-flavored electronic cigarette refill fluidsToxicology in Vitro, 2014
- A case report of subacute bronchial toxicity induced by an electronic cigarette: Table 1Thorax, 2014
- Metal and Silicate Particles Including Nanoparticles Are Present in Electronic Cigarette Cartomizer Fluid and AerosolPLOS ONE, 2013
- Acute respiratory distress syndrome due to exposure to high-concentration mixture of ethenone and crotonaldehydeToxicology and Industrial Health, 2013
- An Unexpected Consequence of Electronic Cigarette UseChest, 2012
- Acute Lung Injury: Epidemiology, Pathogenesis, and TreatmentJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2010
- AEROSOL-ADMINISTERED α-TOCOPHEROL ATTENUATES LUNG INFLAMMATION IN RATS GIVEN LIPOPOLYSACCHARIDE INTRATRACHEALLYExperimental Lung Research, 2005
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDSThorax, 2002